Free Trial
NYSEAMERICAN:HEB

Hemispherx BioPharma (HEB) Stock Price, News & Analysis

Hemispherx BioPharma logo
$6.70 -1.68 (-20.05%)
As of 06/13/2025

About Hemispherx BioPharma Stock (NYSEAMERICAN:HEB)

Key Stats

Today's Range
$5.80
$9.00
50-Day Range
$0.09
$8.38
52-Week Range
$1.69
$14.81
Volume
7,639 shs
Average Volume
102,599 shs
Market Capitalization
$16.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemispherx BioPharma and its competitors with MarketBeat's FREE daily newsletter.

HEB Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Hemispherx Biopharma earnings preview: what Wall Street is expecting
H-E-B hosting hiring fairs
H-E-B opens doors to new Georgetown grocery store
See More Headlines

HEB Stock Analysis - Frequently Asked Questions

Hemispherx BioPharma's stock was trading at $0.2170 at the beginning of 2025. Since then, HEB shares have increased by 2,987.6% and is now trading at $6.70.
View the best growth stocks for 2025 here
.

Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) posted its quarterly earnings data on Thursday, August, 15th. The specialty pharmaceutical company reported ($1.07) EPS for the quarter, topping analysts' consensus estimates of ($1.70) by $0.63. The specialty pharmaceutical company earned $0.03 million during the quarter.

Hemispherx BioPharma's stock reverse split on Tuesday, June 11th 2019.The 1-44 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 10th 2019. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of HEB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemispherx BioPharma investors own include NewLink Genetics (NLNK), Goodrich Petroleum (GDPMQ), Biocept (BIOC), CTI BioPharma (CTIC), Inovio Pharmaceuticals (INO), Palatin Technologies (PTN) and Ayala Pharmaceuticals (ADXS).

Company Calendar

Last Earnings
8/15/2019
Today
7/03/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:HEB
Previous Symbol
NYSE:HEB
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$16.36 million
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSEAMERICAN:HEB) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners